Overview

Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the dose-dependent effects of ONO-1101 on efficacy and safety in patients with postoperative supraventricular tachyarrhythmias.
Phase:
Phase 2
Details
Lead Sponsor:
Ono Pharma USA Inc
Treatments:
Landiolol